Product: Glipizide extended-release tablets, 2.5mg, 30-count bottle,  Rx Only,  Manufactured By Patheon Pharmaceuticals Inc Cincinnati OH 45237 USA, NDC 0591-0900-30, UPC 3-0591090030-4
Reason for recall: Failed Dissolution Specifications. Above out of specification for dissolution rate observed at the 10 hour testing point.
Recall initiated: 20170130
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated